Elizbet Susan Montes-Madariaga

Ms. Elizbet Susan Montes-Madariaga

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
CCCielo Cabanillas-Ramirez
Cielo Cabanillas-Ramirez
NANiza Alva
Niza Alva
APAlex Ricardo Martínez Pajuelo
Alex Ricardo Martínez Pajuelo
Ranjit SahRanjit Sah
Ranjit Sah
The most recent monkeypox (Mpox) outbreak is mostly affecting men who have sex with men (MSM) who participate in high-risk sexual behaviors, which is typically the case among human immunodeficiency virus (HIV) carriers, according to clinical and epidemiological statistics. The objective of this research is to determine the epidemiological situation of HIV and smallpox co-infection. Until 1 October 2022, a thorough evaluation of the literature was conducted utilizing the databases PubMed, Embase, Scopus, and Web of Science. Studies were evaluated based on the criteria for selection. Fifty-three studies met the selection criteria. A total of 6345 confirmed cases of monkeypox were recorded, and 40.32% (n = 2558) of these cases also had HIV co-infection. In addition, 51.36% (n = 3259) of the men (91.44%; n = 5802), whose ages ranged from 18 to 71 years, exhibited MSM-specific sexual behaviors. Co-infection with these two viruses can be especially dangerous because it can exacerbate the symptoms of both diseases and make them more difficult to treat. People with HIV are more vulnerable to certain infections, including monkeypox, because their immune systems are weakened. Therefore, it is important that they take measures to prevent infection, such as avoiding contact with infected animals, risky behaviors, and maintaining good hygiene.

Verified
Journal Article
Open access
PDF file
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
DFDarwin Anthony León Figueroa
Darwin Anthony León Figueroa
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
APAlex Ricardo Martínez Pajuelo
Alex Ricardo Martínez Pajuelo
NANiza Alva
Niza Alva
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
During the COVID-19 pandemic, the increase in reports of human monkeypox virus infection cases spreading in many countries outside Africa is a major cause for concern. Therefore, this study aimed to explore the evidence of antiviral pharmacotherapy available for the treatment of adult patients with monkeypox. A scoping review of the literature was conducted using PubMed, Scopus, Web of Science, Embase, and CENTRAL databases until 12 September 2022. The key search terms used were “monkeypox” and “treatment”. A total of 1927 articles were retrieved using the search strategy. After removing duplicates (n = 1007) and examining by title, abstract, and full text, 11 studies reporting case reports of monkeypox with antiviral treatment were included, detailing the number of monkeypox cases, clinical manifestations, number of participants with antiviral treatment, history of sexually transmitted diseases, method of diagnosis, location of skin lesions, drugs used in antiviral treatment, route of administration, and outcome. A total of 1281 confirmed cases of monkeypox have been reported, of which 65 monkeypox cases had antiviral treatment distributed most frequently in the United States (n = 30), the United Kingdom (n = 6), and Spain (n = 6). Of the total cases, 1269 (99.1%) were male with an age range of 18 to 76 years, and 1226 (95.7%) had a sexual behavior of being men who have sex with men. All confirmed cases of monkeypox were diagnosed by reverse transcriptase polymerase chain reaction (RT-PCR). The most frequent clinical manifestations were skin lesions, fever, lymphadenopathy, headache, fatigue, and myalgia. The most frequent locations of the lesions were perianal, genital, facial, and upper and lower extremities. The most commonly used drugs for antiviral treatment of monkeypox were: tecovirimat, cidofovir, and brincidofovir. All patients had a complete recovery. According to current evidence, the efficacy and safety of antiviral drugs against monkeypox is of low quality and scarce.

1 December 2021 in High Altitude Medicine & Biology
Verified
Journal Article
Closed access
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
JZJessica Hanae Zafra-Tanaka
Jessica Hanae Zafra-Tanaka
OMOscar Moreno-Loaiza
Oscar Moreno-Loaiza
High Altitude Medicine & Biology

1 March 2024 in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
Verified
Journal Article
Open access
PDF file
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
EAEuler Altamirano-Farfan
Euler Altamirano-Farfan
MHMelissa Herencia-Anaya
Melissa Herencia-Anaya
JPJimmy Pumamango-Cordova
Jimmy Pumamango-Cordova
▪ RESUMO: O tumor filoide é uma neoplasia fibroepitelial rara que representa 0,3 a 1% de todas as neoplasias mamárias. De acordo com a classificação histopatológica, 12 a 26% são do tipo borderline e aproximadamente 15% desses tumores recorrem após excisão cirúrgica. O tratamento recomendado para todos os tipos de tumor filoide é a excisão cirúrgica, e no caso de tumores gigantes o tratamento deve ser multidisciplinar. Apresentamos o caso de uma mulher de 46 anos com tumor filoide na mama esquerda que recorreu 4 anos após a excisão cirúrgica. O estudo anatomopatológico qualificou-o como tumor gigante e o estudo histopatológico relatou tumor filoide borderline. Foi submetida a excisão cirúrgica com mastectomia esquerda e reconstrução mamária com retalho de grande dorsal mais enxerto de gordura. A paciente apresentou evolução favorável sem recidiva. Concluindo, o tumor filoide gigante borderline recorrente é raro e seu manejo cirúrgico representa um desafio tanto na excisão quanto na reconstrução mamária.

1 January 2024 in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
Verified
Journal Article
Open access
PDF file
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
EAEuler Altamirano-Farfan
Euler Altamirano-Farfan
MHMelissa Herencia-Anaya
Melissa Herencia-Anaya
JPJimmy Pumamango-Cordova
Jimmy Pumamango-Cordova
A Revista Brasileira de Cirurgia Plástica é o órgão oficial de divulgação da Sociedade Brasileira de Cirurgia Plástica (SBCP), tem como objetivo registrar a produção científica em Cirurgia Plástica, fomentar o estudo, aperfeiçoamento e atualização dos profissionais da especialidade.

1 January 2024 in Revista Brasileira de Cirurgia Plástica (RBCP) – Brazilian Journal of Plastic Surgery
Verified
Journal Article
Open access
PDF file
EMElizbet Susan Montes-Madariaga
Elizbet Susan Montes-Madariaga
BOBrando Ortiz-Saavedra
Brando Ortiz-Saavedra
EAEuler Altamirano-Farfan
Euler Altamirano-Farfan
JPJimmy Pumamango-Cordova
Jimmy Pumamango-Cordova
MHMelissa Herencia-Anaya
Melissa Herencia-Anaya
A Revista Brasileira de Cirurgia Plástica é o órgão oficial de divulgação da Sociedade Brasileira de Cirurgia Plástica (SBCP), tem como objetivo registrar a produção científica em Cirurgia Plástica, fomentar o estudo, aperfeiçoamento e atualização dos profissionais da especialidade.